CytoVas, BD Biosciences Developing Dx for Vascular Health | GenomeWeb

NEW YORK (GenomeWeb News) – CytoVas and BD Biosciences entered into a strategic alliance to develop a blood-based diagnostic test for predicting a patient's risk of heart attack and stroke.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.